Status:
COMPLETED
Transarterial Radioembolization (TARE) in COlorectal MEtastasis of Liver
Lead Sponsor:
Ankara University
Collaborating Sponsors:
Boston Scientific Corporation
Conditions:
Transarterial Radioembolization
Eligibility:
All Genders
18+ years
Brief Summary
Radioembolization is an established treatment option for patients with unresectable primary and secondary liver tumors. Microspheres containing 90Y are injected intraarterially to deliver a high radia...
Eligibility Criteria
Inclusion
- over 18 years old
- histopathologically proven colorectal cancer diagnosis
- treated with radioembolization for liver metastases with Y90 glass microspheres in lobar or segmental fashion
- have follow-up data at least 6 months after radioembolization
Exclusion
- no PET-CT, CT or MR of the liver within last 6 weeks prior to radioembolization.
- No PET-CT, CT or MR of the liver 2-4 months after radioembolization Poor image quality Previous local treatment or surgery for the liver
Key Trial Info
Start Date :
January 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 15 2024
Estimated Enrollment :
202 Patients enrolled
Trial Details
Trial ID
NCT06030232
Start Date
January 15 2024
End Date
April 15 2024
Last Update
April 24 2024
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Cukurova University Medical School
Adana, Turkey (Türkiye)
2
Ankara University Medical School
Ankara, Turkey (Türkiye)
3
Hacettepe Univeristy Medical School
Ankara, Turkey (Türkiye)
4
Istanbul University Capa Medical School
Istanbul, Turkey (Türkiye)